Product Information
GS PAIN RLF PM 25-500 MG CPLT is a generic product labeled by L. Perrigo Company, priced at $0.0439 per EA under NDC 00113043771. Its NADAC has been published 595 times since Nov 28, 2013.
Strength
500; 25 mg/1; mg/1
Manufacturer
L. Perrigo CompanyNDC
00113043771
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
7/23/1992
Pharmacological Classes
Price Statistics
The NADAC for GS PAIN RLF PM 25-500 MG CPLT has been published 595 times since Nov 28, 2013, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0439 per EA |
|---|---|
| All-time high | $0.0552 (Dec 11, 2024) |
| All-time low | $0.0350 (Sep 23, 2015) |
| 52-week high | $0.0470 |
| 52-week low | $0.0439 |
| Median price | $0.0434 |
| Average price | $0.0437 |
| Largest weekly change | +18.4% (Sep 21, 2022) |
| Weeks tracked | 595 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Diphenhydramine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS PAIN RLF PM 25-500 MG CPLT?
The current National Average Drug Acquisition Cost (NADAC) for GS PAIN RLF PM 25-500 MG CPLT, manufactured by L. Perrigo Company, is $0.0439 per EA (NDC 00113043771), effective Sep 30, 2026.
How has the price of GS PAIN RLF PM 25-500 MG CPLT changed over time?
Over the history we have for it, the NADAC for GS PAIN RLF PM 25-500 MG CPLT has risen 2.9%. It has been tracked across 595 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GS PAIN RLF PM 25-500 MG CPLT?
Since Nov 28, 2013, the NADAC for GS PAIN RLF PM 25-500 MG CPLT has ranged from a low of $0.0350 (Sep 23, 2015) to a high of $0.0552 (Dec 11, 2024), with a median of $0.0434 per EA.
Are there cheaper alternatives to GS PAIN RLF PM 25-500 MG CPLT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS PAIN RLF PM 25-500 MG CPLT in a comparable dosage form, but none are currently priced below it.
Who manufactures GS PAIN RLF PM 25-500 MG CPLT?
GS PAIN RLF PM 25-500 MG CPLT (NDC 00113043771) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.